AWARENESS

The general public doesn’t realize the magnitude of problems faced by children and adolescents with cancer and those who survive their cancers.  The Awareness Interest Group seeks to shine the spotlight on facts, such as:

  • Childhood cancer is the leading cause of death by disease among children and adolescents in the United States.
  • Most causes of childhood cancer are unknown and not preventable.
  • The incidence of childhood cancer is on the increase.
  • Most survivors will experience significant debilitating complications that result from their treatment regimes.
  • Children and adolescents who have or have had cancer are much more likely (more than 60%) to face bullying than their healthy classmates.
  • Only four drugs have been developed and approved to treat a pediatric cancer in the last quarter century.

CAC2 member organizations with an interest in Awareness are encouraged to participate in the work of the CAC2 Advocacy and Awareness Interest Group. Notes from the 2019 meeting of the working group are available here. Email if you would like more information on how to be involved with CAC2 awareness initiatives.

Raising awareness is crucial to increasing research funds and legislative efficacy.
Collaborating amplifies our impact.

Latest CAC2 and Community News

CAC2 Childhood Cancer Community News Digest (December 2-8)

Assorted News from the Last Week: CAC2 Individual Member Jennifer Flowers writes compellingly about "When the National Drug Shortage Becomes Personal" for her. Published in JAMA: "Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers." Many CAC2 Members ...

CAC2 Advocacy Alert: End-of-Year Call to Action

During our October federal advocacy drop-in session, we learned about several pieces of legislation that had a good chance to pass before the end of the year and also alerted everyone that "advocates may be called on to make a ...

CAC2 Childhood Cancer Community News Digest (November 26-December 1)

Assorted News from the Last Week: Last week the FDA reported that it is investigating reports of blood cancers -- including life-threatening cases of myelodysplastic syndrome and acute myeloid leukemia -- in patients with early, active cerebral adrenoleukodystrophy (CALD) who ...